Analogous to the cell lines, the PDXs T-ALL-27 and T-ALL-44 (exhibiting low sensitivity to the PLK1 inhibitor) displayed increased synergy as determined by both the BLISS score and combination index (Fig. 4B). This evidence concerns the gene PLK1 and acute lymphoblastic leukemia.